FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / form-1572-preparation-memo.docx
form-1572-preparation-memo.docx · 1018-00004

Parties

Harkness LLP
Penterra Pharmaceuticals Corp
Hargrove LLP

Dates

April 12, 2023
April 7, 2023
July 5, 2023
August 14, 2023
January 21, 2019
January 15, 2023
June 23, 2023
October 3, 2023

Amounts

—

Obligations

Accordingly, the Form 1572 collection process described in this memorandum is integral to, and must proceed in coordination with, the broader MCTA negotiation and site activation process
Within this framework, the Form 1572 serves as the primary mechanism by which an investigator formally agrees to participate in a clinical investigation and to abide by the regulatory requirements applicable to the conduct of that investigation
The investigator is required to attach a current curriculum vitae ("CV") and, where applicable, documentation of relevant training and experience
Protocol Details The essential protocol parameters that must be correctly referenced in each Form 1572 are as follows: Each Form 1572 must accurately reference the protocol number (PPC-4871-III) and the protocol title
Each Form 1572 must reference the correct site name and address, and the site information on the form must match the information set forth in Schedule 1 to the MCTA
Each of the remaining thirty-six (36) Veridian Network sites will designate a site principal investigator who must also complete and execute a Form 1572